Compounds > 2-oxindole
Page last updated: 2024-08-24

2-oxindole and Prostatic Neoplasms

2-oxindole has been researched along with Prostatic Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, J; Li, H; Liu, X; Xu, Y; Xue, M; Yuan, J; Zhao, X; Zhao, Z; Zhong, Y1
Naidu, VG; Reddy, TS; Senwar, KR; Shankaraiah, N; Sharma, P; Srinivasulu, G; Thummuri, D1
Abdel-Aziz, HA; Alsherbiny, MA; Aly, MH; Eldehna, WM; Fares, M; Ghabbour, HA; Ibrahim, HS1
Bort, A; Castro, A; Díaz-Laviada, I; Gargantilla, M; Gasalla, JM; Lepifre, F; Priego, EM; Quesada, S; Ramos-Torres, Á; Raynal, S; Rodriguez-Henche, N1

Other Studies

4 other study(ies) available for 2-oxindole and Prostatic Neoplasms

ArticleYear
Substituted indolin-2-ones as p90 ribosomal S6 protein kinase 2 (RSK2) inhibitors: Molecular docking simulation and structure-activity relationship analysis.
    Bioorganic & medicinal chemistry, 2013, Apr-01, Volume: 21, Issue:7

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Indoles; Male; Molecular Docking Simulation; Prostatic Neoplasms; Protein Kinase Inhibitors; Ribosomal Protein S6 Kinases, 90-kDa; Structure-Activity Relationship

2013
Design, synthesis and apoptosis inducing effect of novel (Z)-3-(3'-methoxy-4'-(2-amino-2-oxoethoxy)-benzylidene)indolin-2-ones as potential antitumour agents.
    European journal of medicinal chemistry, 2016, Aug-08, Volume: 118

    Topics: Actins; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Design; Humans; Indoles; Male; Prostatic Neoplasms

2016
Synthesis and Cytotoxic Activity of Biphenylurea Derivatives Containing Indolin-2-one Moieties.
    Molecules (Basel, Switzerland), 2016, Jun-10, Volume: 21, Issue:6

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Doxorubicin; Drug Screening Assays, Antitumor; Female; Humans; Indoles; Male; MCF-7 Cells; Prostatic Neoplasms; Rhodamines; Structure-Activity Relationship; Urea

2016
Identification of a novel 2-oxindole fluorinated derivative as in vivo antitumor agent for prostate cancer acting via AMPK activation.
    Scientific reports, 2018, 03-12, Volume: 8, Issue:1

    Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Halogenation; Humans; Male; Oxindoles; Phosphorylation; Prostatic Neoplasms; Protein Isoforms

2018